The insider sale is small and follows a stock option exercise, which is routine for executive compensation. No immediate catalyst is indicated. Monitor for any subsequent Form 4 filings to confirm whether the sale was executed and at what price.
Price Chart
Executive Summary
John M. Evans, an officer and director of Beam Therapeutics, filed a Form 144 notice to sell 25,000 common shares with an estimated aggregate market value of $599,595. The shares were acquired via a stock option exercise on October 16, 2026, and the sale is proposed for the same day. The sale represents a modest portion of the insider's total holdings and is not a large-scale liquidation.
Key Facts
- Insider John M. Evans (officer and director) filed Form 144 to sell 25,000 shares of Beam Therapeutics common stock.
- Estimated aggregate market value of the proposed sale is $599,595.
- Shares were acquired via a stock option exercise on October 16, 2026.
- The sale is proposed for the same day as the filing (October 16, 2026).
- The insider's total holdings are not fully disclosed, but the sale amount is small relative to the company's market cap.
Financial Impact
Proposed sale of 25,000 shares valued at approximately $599,595, which is a small fraction of the company's market cap.
Risk Factors
- Insider selling, even if routine, can signal a lack of confidence if it becomes a pattern.
- The sale may be part of a pre-arranged trading plan (Rule 10b5-1), but no such plan is mentioned in the filing.
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001950047-26-010282 |
| Document: 0001950047-26-010282-index.html | 0001950047-26-010282 |
| Document: 0001950047-26-010282.txt | 0001950047-26-010282 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 16, 2026 10d ago | 144 | $24.19 $23.79 | ▼ −1.65% | ▼ −1.51% | $23.89 (−1.24%) |
Aug 15, 2026 10w ago | Institutional Cluster | $27.10 $28.33 | ▲ +4.54% | ▲ +5.73% | $23.89 (−11.85%) |
Jul 2, 2026 16w ago | Insider Cluster | $34.79 $35.82 | ▲ +2.96% | ▲ +2.03% | $23.89 (−31.33%) |
Jul 1, 2026 16w ago | Insider Cluster | $34.79 $32.68 | ▲ +6.07% | ▲ +7.43% | $23.89 (+31.33%) |
May 12, 2026 24w ago | Press Release | $31.58 $26.81 | ▼ −15.10% | ▼ −15.18% | $23.89 (−24.35%) |
Apr 17, 2026 27w ago | DEFA14A | $31.19 $29.17 | ▼ −6.49% | ▼ −7.41% | $23.89 (−23.40%) |
Mar 25, 2026 30w ago | Press Release | $23.12 $24.22 | ▲ +4.76% | ▲ +5.00% | $23.89 (+3.33%) |
Mar 5, 2026 33w ago | 8-K | $26.54 $25.16 | ▼ −5.20% | ▼ −3.67% | $23.89 (−9.98%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers